Healthcare101

  Metabolism Assays Market in terms of revenue was estimated to be worth $1.4 billion in 2023 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rising initiatives by government to promote metabolic & disease research, innovation in metabolism assays technology by integrating with wearable devices, increase in prevalence of metabolic disorders such as diabetes and obesity, and adoption of metabolism assays by fitness and sports industries. ​ Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=135163479 Browse in-depth TOC on "Metabolism Assays Market" 126 - Tables 38 - Figures 192 – Pages Assay Kits and reagents segment is expected to account for the larger share in 2022. The metabolism assay market, by product, has been segmented into instruments & analyzers and assay kits & reagents. In 2022...

  Metabolism Assays Market in terms of revenue was estimated to be worth $1.4 billion in 2023 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rising initiatives by government to promote metabolic & disease research, innovation in metabolism assays technology by integrating with wearable devices, increase in prevalence of metabolic disorders such as diabetes and obesity, and adoption of metabolism assays by fitness and sports industries. Metabolism Assays Market Trends Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=135163479 Assay Kits and reagents segment is expected to account for the larger share in 2022. The metabolism assay market, by product, has been segmented into instruments & analyzers and assay kits & reagents. In 2022, the assay kits & reagents dominated the products mar...

  The   Metabolism Assays Market   is projected to reach USD 2.1 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 7.8% during the forecast period. The growth in this market is attributed to the growing prevalence of diabetes, the global increase in the number of hospitals, and the high rate of obese population. However, alternative methods or techniques restrain the growth of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=135163479 Global Metabolism Assays Dynamics DRIVER: Increasing funding and investments in metabolic research Metabolic research funding and investments are crucial for advancing the metabolic processes understanding, producing new metabolic disease treatments, and improving public health. Diseases like diabetes, obesity, lipid metabolism, mitochondrial disorders, and metabolic pathways are being considered as metabolic diseases. Various sources, including government agencies, private foundations, pha...